Market Cap 20.31B
Revenue (ttm) 9.87B
Net Income (ttm) 871.00M
EPS (ttm) N/A
PE Ratio 18.80
Forward PE 18.55
Profit Margin 8.82%
Debt to Equity Ratio 0.78
Volume 1,138,900
Avg Vol 1,115,548
Day's Range N/A - N/A
Shares Out 111.24M
Stochastic %K 61%
Beta 0.62
Analysts Sell
Price Target $198.76

Company Profile

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 973 520 2700
Address:
500 Plaza Drive, Secaucus, United States
joshua_moore23
joshua_moore23 Dec. 12 at 5:50 PM
$DGX Mainz Biomed 1.04–1.14 for days with no new lows is time-based basing, not weakness, and when you overlay the market math of ~1,926,425 global CRC cases per year it’s hard not to think this gets re-rated when volume returns
0 · Reply
gaineous
gaineous Dec. 12 at 2:58 PM
$ONDS $DGX $AMT $ODD $YOU already know!
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 12 at 2:17 PM
$DGX RSI: 37.54, MACD: -0.7871 Vol: 3.83, MA20: 185.54, MA50: 183.33 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 11:10 PM
Actionable Trade Alert for $DGX: Market Context: $DGX is currently trading at $181.86, showing a bearish sentiment with an RSI of 38.28, indicating potential oversold conditions. The price is below both the 30-day (183.8) and 50-day (183.35) moving averages, suggesting a downward trend. However, the proximity to the 60-day low of $174.33 may present a reversal opportunity. Directional Bias: The current RSI and moving averages indicate a potential bounce back. The ATR of 3.05 suggests volatility, which can be advantageous for traders. Trade Plan: - Suggested Entry: $181.86 - Stop Loss: $178.00 (approximately 2.5% risk) - Take Profit Targets: 1. $185.00 (1.17% gain) 2. $190.00 (4.47% gain) 3. $213.00 (17.17% gain) This plan capitalizes on a potential reversal, with a strong upside target that exceeds 17% ROI. Monitor the price action closely for adjustments. https://privateprofiteers.com
0 · Reply
BEGUIN
BEGUIN Dec. 10 at 3:06 PM
$NVDA Moat and ecosystem The CUDA ecosystem (18+ years of tools and libraries) and Nvidia’s networking stack make switching away from its platform costly and complex for large customers. New software and services layers ($DGX Cloud, NIMs, microservices) mean Nvidia is capturing more of the AI value chain over time. This combination of IP, software integration and recurring-like demand is closer to a “platform” profile than a commodity chip vendor, which supports a higher-than-market multiple
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 3:14 AM
Actionable Trade Alert for $DGX: Market Context: $DGX closed at $179.62, showing potential for upward movement given the current RSI of 38.3, indicating it is nearing oversold territory. The stock is trading below its 30-day (MA30) and 50-day (MA50) moving averages, which are at $183.52 and $183.58, respectively. The recent 60-day high of $197.55 suggests room for recovery. Directional Bias: The RSI indicates potential bullish momentum as it approaches oversold conditions. The proximity to the 60D low of $174.33 provides a solid support level. Trade Plan: - Suggested Entry: $179.62 - Stop Loss: $174.00 (approximately 3.6% below entry) - Take Profit Targets: 1. Target 1: $185.00 (3% gain) 2. Target 2: $190.00 (5.8% gain) 3. Target 3: $210.00 (16.9% gain) This plan offers a potential ROI of over 17% on the third target, aligning with market recovery indicators. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 8 at 11:02 PM
Actionable Trade Alert for $DGX: Market Context: $DGX closed at $182.5, with an RSI of 41.74 indicating it is approaching oversold territory. The stock is currently below its 30-day (183.56) and 50-day (183.78) moving averages, suggesting a bearish short-term trend. However, the proximity to the 60-day low of 174.33 presents a potential reversal opportunity. Directional Bias: The RSI indicates potential for upward movement as it nears the oversold threshold. The recent price action within the high-low range (197.55 - 174.33) supports a bounce back towards the higher end. Trade Plan: - Suggested Entry: $182.5 - Stop Loss: $177.5 (3% below entry) - Take Profit Targets: 1. $188.5 (3% gain) 2. $195.0 (6.8% gain) 3. $214.0 (17.3% gain) This trade offers a favorable risk-reward ratio with a potential for over 17% ROI on the third target. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
TradeInYourJob
TradeInYourJob Dec. 6 at 6:37 PM
$DGX Sell signal triggered on the monthly timeframe CCI.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:02 AM
Actionable Trade Alert for $DGX: Market Context: $DGX is currently trading at $184.18, showing a neutral RSI of 42.29, indicating a potential for upward movement as it is not overbought. The price is above the 30-day MA of $183.58 but below the 50-day MA of $183.97, suggesting a consolidation phase. The 60-day high of $197.55 and low of $174.33 indicates a range that can be exploited for potential gains. Directional Bias: Slight bullish bias due to the current price being above the 30-day MA and nearing the lower end of the 60-day range. Trade Plan: - Suggested Entry: $184.50 - Stop Loss: $179.50 (approximately 2.0% risk) - Take Profit Targets: 1. $190.00 (3.0% gain) 2. $195.00 (5.8% gain) 3. $216.00 (17.3% gain) This plan provides a solid risk-reward ratio with a potential for over 17% ROI on the final target. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 3 at 3:04 AM
$DGX Current Stock Price: $182.42 Contracts to trade: $180 DGX Dec 19 2025 Call Entry: $4.80 Exit: $7.55 ROI: 57% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Latest News on DGX
Digi Power X Inc. (DGX:CA) Q3 2025 Earnings Call Transcript

Nov 14, 2025, 10:31 AM EST - 4 weeks ago

Digi Power X Inc. (DGX:CA) Q3 2025 Earnings Call Transcript

DGXX


Quest Diagnostics Declares Quarterly Cash Dividend

Nov 11, 2025, 4:22 PM EST - 4 weeks ago

Quest Diagnostics Declares Quarterly Cash Dividend


Quest Diagnostics: Investing In Healthcare's Future Today

Oct 6, 2025, 12:49 AM EDT - 2 months ago

Quest Diagnostics: Investing In Healthcare's Future Today


Quest Diagnostics: A Solid Investment or a Risky Bet?

Sep 4, 2025, 7:00 PM EDT - 3 months ago

Quest Diagnostics: A Solid Investment or a Risky Bet?


Quest Diagnostics Raises 2025 Guidance

Jul 22, 2025, 5:02 PM EDT - 5 months ago

Quest Diagnostics Raises 2025 Guidance


Quest Diagnostics Boosts Its 2025 Outlook

Jul 22, 2025, 2:19 PM EDT - 5 months ago

Quest Diagnostics Boosts Its 2025 Outlook


Quest Diagnostics Introduces Testing for Oropouche Virus

Jul 15, 2025, 7:57 AM EDT - 5 months ago

Quest Diagnostics Introduces Testing for Oropouche Virus


Quest Diagnostics Releases 2024 Corporate Responsibility Report

Jun 25, 2025, 9:07 AM EDT - 6 months ago

Quest Diagnostics Releases 2024 Corporate Responsibility Report


Quest Diagnostics: A Leader But Waiting For Better Price

May 3, 2025, 4:26 AM EDT - 8 months ago

Quest Diagnostics: A Leader But Waiting For Better Price


joshua_moore23
joshua_moore23 Dec. 12 at 5:50 PM
$DGX Mainz Biomed 1.04–1.14 for days with no new lows is time-based basing, not weakness, and when you overlay the market math of ~1,926,425 global CRC cases per year it’s hard not to think this gets re-rated when volume returns
0 · Reply
gaineous
gaineous Dec. 12 at 2:58 PM
$ONDS $DGX $AMT $ODD $YOU already know!
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 12 at 2:17 PM
$DGX RSI: 37.54, MACD: -0.7871 Vol: 3.83, MA20: 185.54, MA50: 183.33 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 11 at 11:10 PM
Actionable Trade Alert for $DGX: Market Context: $DGX is currently trading at $181.86, showing a bearish sentiment with an RSI of 38.28, indicating potential oversold conditions. The price is below both the 30-day (183.8) and 50-day (183.35) moving averages, suggesting a downward trend. However, the proximity to the 60-day low of $174.33 may present a reversal opportunity. Directional Bias: The current RSI and moving averages indicate a potential bounce back. The ATR of 3.05 suggests volatility, which can be advantageous for traders. Trade Plan: - Suggested Entry: $181.86 - Stop Loss: $178.00 (approximately 2.5% risk) - Take Profit Targets: 1. $185.00 (1.17% gain) 2. $190.00 (4.47% gain) 3. $213.00 (17.17% gain) This plan capitalizes on a potential reversal, with a strong upside target that exceeds 17% ROI. Monitor the price action closely for adjustments. https://privateprofiteers.com
0 · Reply
BEGUIN
BEGUIN Dec. 10 at 3:06 PM
$NVDA Moat and ecosystem The CUDA ecosystem (18+ years of tools and libraries) and Nvidia’s networking stack make switching away from its platform costly and complex for large customers. New software and services layers ($DGX Cloud, NIMs, microservices) mean Nvidia is capturing more of the AI value chain over time. This combination of IP, software integration and recurring-like demand is closer to a “platform” profile than a commodity chip vendor, which supports a higher-than-market multiple
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 3:14 AM
Actionable Trade Alert for $DGX: Market Context: $DGX closed at $179.62, showing potential for upward movement given the current RSI of 38.3, indicating it is nearing oversold territory. The stock is trading below its 30-day (MA30) and 50-day (MA50) moving averages, which are at $183.52 and $183.58, respectively. The recent 60-day high of $197.55 suggests room for recovery. Directional Bias: The RSI indicates potential bullish momentum as it approaches oversold conditions. The proximity to the 60D low of $174.33 provides a solid support level. Trade Plan: - Suggested Entry: $179.62 - Stop Loss: $174.00 (approximately 3.6% below entry) - Take Profit Targets: 1. Target 1: $185.00 (3% gain) 2. Target 2: $190.00 (5.8% gain) 3. Target 3: $210.00 (16.9% gain) This plan offers a potential ROI of over 17% on the third target, aligning with market recovery indicators. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 8 at 11:02 PM
Actionable Trade Alert for $DGX: Market Context: $DGX closed at $182.5, with an RSI of 41.74 indicating it is approaching oversold territory. The stock is currently below its 30-day (183.56) and 50-day (183.78) moving averages, suggesting a bearish short-term trend. However, the proximity to the 60-day low of 174.33 presents a potential reversal opportunity. Directional Bias: The RSI indicates potential for upward movement as it nears the oversold threshold. The recent price action within the high-low range (197.55 - 174.33) supports a bounce back towards the higher end. Trade Plan: - Suggested Entry: $182.5 - Stop Loss: $177.5 (3% below entry) - Take Profit Targets: 1. $188.5 (3% gain) 2. $195.0 (6.8% gain) 3. $214.0 (17.3% gain) This trade offers a favorable risk-reward ratio with a potential for over 17% ROI on the third target. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
TradeInYourJob
TradeInYourJob Dec. 6 at 6:37 PM
$DGX Sell signal triggered on the monthly timeframe CCI.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 2:02 AM
Actionable Trade Alert for $DGX: Market Context: $DGX is currently trading at $184.18, showing a neutral RSI of 42.29, indicating a potential for upward movement as it is not overbought. The price is above the 30-day MA of $183.58 but below the 50-day MA of $183.97, suggesting a consolidation phase. The 60-day high of $197.55 and low of $174.33 indicates a range that can be exploited for potential gains. Directional Bias: Slight bullish bias due to the current price being above the 30-day MA and nearing the lower end of the 60-day range. Trade Plan: - Suggested Entry: $184.50 - Stop Loss: $179.50 (approximately 2.0% risk) - Take Profit Targets: 1. $190.00 (3.0% gain) 2. $195.00 (5.8% gain) 3. $216.00 (17.3% gain) This plan provides a solid risk-reward ratio with a potential for over 17% ROI on the final target. https://privateprofiteers.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 3 at 3:04 AM
$DGX Current Stock Price: $182.42 Contracts to trade: $180 DGX Dec 19 2025 Call Entry: $4.80 Exit: $7.55 ROI: 57% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Trade2Win2019
Trade2Win2019 Nov. 24 at 11:21 PM
$DGX good short idea right here 🐻📉📉📉🩸
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Nov. 24 at 2:57 PM
$DGX RSI: 74.20, MACD: 2.0364 Vol: 5.47, MA20: 182.87, MA50: 183.42 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ZacksResearch
ZacksResearch Nov. 24 at 2:13 PM
$DGX up 17.8% in a year against industry’s 0.1% decline — can the rally continue? 📈 Quest Diagnostics’ strategic acquisitions and investments in advanced diagnostics are driving growth, with an earnings yield above industry average and an average earnings surprise of 2.5% 🔍. However, rising debt and stiff competition pose challenges ⚠️. Discover what could impact DGX's performance next 👉 https://www.zacks.com/stock/news/2794563/should-you-hold-quest-diagnostics-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2794563-body-22185&ADID=SYND_STOCKTWITS_TWEET_2_2794563_BODY_22185
0 · Reply
ZacksResearch
ZacksResearch Nov. 24 at 1:13 PM
Is $DGX still worth holding while the pressure builds? The company is driving growth through acquisitions and advanced diagnostics, but rising debt and tough competition are weighing on its outlook — a real mixed setup for investors. Full risk/reward rundown here 👉 https://www.zacks.com/stock/news/2794563/should-you-hold-quest-diagnostics-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2794563-teaser-22183&ADID=SYND_STOCKTWITS_TWEET_2_2794563_TEASER_22183
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 21 at 7:32 PM
🎯 Target Hit 🏁 📨 From Nov 11, 2025 🏛️ $DGX 💵 Entry: $188.8800 ✅ Exit: $193.4320 💰 P/L: +2.41% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
gaineous
gaineous Nov. 19 at 3:46 PM
Bullish for 2026 Complete Conviction $AMT $ODD $ONDS $YOU $DGX Above Ave Conviction ATEC DOCU ZM Forever Holds AXP EXPE WMT UBER *EQIX interesting; seems undervalued at first glance.
0 · Reply
notreload_ai
notreload_ai Nov. 13 at 5:09 PM
$HIMS , $DGX , $LH ... Hims & Hers Health launches lab testing with Quest Diagnostics, offering affordable biomarker tests and personalized health plans as part of its preventive care expansion. https://notreload.xyz/hims-launches-affordable-lab-testing/
0 · Reply
NVDAMillionaire
NVDAMillionaire Nov. 3 at 6:46 PM
$DGX Outstanding article that hits the mark on DGX's current state. So if you want to refresh your DGX insights or learn about DGX from scratch, this is a must read. https://beyondspx.com/quote/DGX/analysis/quest-diagnostics-accelerating-growth-with-advanced-diagnostics-and-strategic-market-capture-dgx
0 · Reply
Halo202
Halo202 Nov. 2 at 9:47 PM
$DGX $180+ by Friday
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 31 at 12:17 PM
$DGX RSI: 36.45, MACD: -1.2211 Vol: 4.17, MA20: 182.43, MA50: 182.13 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 31 at 11:53 AM
$DGX Share Price: $175.84 Contract Selected: Feb 20, 2026 $175 Calls Buy Zone: $7.61 – $9.40 Target Zone: $12.22 – $14.94 Potential Upside: 52% ROI Time to Expiration: 111 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
prismmarketview
prismmarketview Oct. 27 at 6:38 PM
(NYSE: $DGX) Quest Diagnostics reported its AD-Detect Alzheimer’s blood tests show 91% sensitivity and specificity, matching more invasive methods for identifying brain markers. https://prismmarketview.com/quest-diagnostics-posts-strong-study-results-for-its-ad-detect-alzheimers-blood-tests/
0 · Reply